Home/Filings/4/0001127602-12-032424
4//SEC Filing

CLAYPOOL WILLIAM D MD 4

Accession 0001127602-12-032424

CIK 0000946840other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 4:22 PM ET

Size

13.0 KB

Accession

0001127602-12-032424

Insider Transaction Report

Form 4
Period: 2012-11-28
Transactions
  • Sale

    Common Stock

    2012-11-28$24.22/sh2,500$60,55454,500 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-11-2815,0000 total
    Exercise: $10.76From: 2011-02-22Exp: 2020-02-22Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-11-28$5.68/sh+2,500$14,20057,000 total
  • Exercise/Conversion

    Common Stock

    2012-11-28$10.76/sh+15,000$161,40069,500 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2012-11-282,5000 total
    Exercise: $5.68From: 2010-02-23Exp: 2019-02-22Common Stock (2,500 underlying)
  • Sale

    Common Stock

    2012-11-28$24.22/sh15,000$363,32654,500 total
Footnotes (2)
  • [F1]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $24.12 to $24.28, inclusive.
  • [F2]The options vest in full one year from date of grant.

Issuer

VIROPHARMA INC

CIK 0000946840

Entity typeother

Related Parties

1
  • filerCIK 0001273313

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 4:22 PM ET
Size
13.0 KB